Dubai - Mubasher: Jebel Ali Free Zone (Jafza) has announced that it would showcase the growth opportunities it offers to the healthcare and pharmaceutical industry at the Arab Health 2018 Conference and Exhibition from 29 January to 1 February.
Jafza currently houses 306 healthcare and pharmaceutical companies from 54 countries, which includes Roche, Johnson & Johnson, Glaxo Smith & Kline (GSK), L'Oreal, Sanofi, Life Pharma, among others.
In 2016, trade in the healthcare and pharmaceutical sectors at Jafza registered AED 14.2 billion ($3.86 billion), which makes up around a quarter of the UAE’s AED 59 billion ($16.1 billion) health expenditure in the same year, Jafza revealed.
“The healthcare and pharmaceutical [segments] are key strategic targets in the Dubai Industrial Strategy 2030. As as a trade and logistics hub, Jafza fully supports this vision and we are determined to help it grow,” said Sultan Bin Sulayem, DP World’s chairman and CEO.
The UAE pharmaceutical and healthcare sector is expected to grow to $17.88 billion in 2018 from $16.96 billion in 2017 and to register $21.27 billion in 2021, according to a BMI Research report.
“DP World is committed to creating an ideal business investment environment through industry-specific initiatives and incentives and we are fully behind the government’s aim of making Dubai an international hub for knowledge-based, innovative and sustainable industrial activities," Bin Sulayem added.
Jafza's participation in Arab Health 2018 "will highlight the prospects for global healthcare majors in the region as we seek to attract more investors to this thriving business community,” DP World's top official concluded.
